Dow Jones

39,331.85

0.41%

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Eucrates Biomedical Acquisition Corporation (EUCRU)
Eucrates Biomedical Acquisition Corporation (EUCRU) Noticias

EUCRU

Eucrates Biomedical Acqu... (EUCRU)

Eucrates Biomedical Acquisition Corporation

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:EUCRU

1

Fecha	Hora	Fuente	Título	Símbolo	Compañía
26/04/2023	15:53	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
11/04/2023	16:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
29/03/2023	15:41	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
10/02/2023	08:44	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
14/11/2022	16:37	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
05/10/2022	16:21	Edgar (US Regulatory)	Proxy Soliciting Materials (revised) (prer14a)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
16/05/2022	15:50	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
11/04/2022	05:04	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
14/02/2022	13:43	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
20/12/2021	15:34	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
14/12/2020	16:22	PR Newswire (US)	Eucrates Biomedical Acquisition Corp. Announces The Separate Trading Of Its Ordinary Shares And Redeemable Warrants	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation
27/10/2020	15:17	PR Newswire (US)	Eucrates Biomedical Acquisition Corp. Announces Closing Of $100 Million Initial Public Offering	NASDAQ:EUCRU	Eucrates Biomedical Acquisition Corporation